Drug trial reverses patients' biological age by an average of more than two years

Brasil Notícia Notícia

Drug trial reverses patients' biological age by an average of more than two years
Brasil Últimas Notícias,Brasil Manchetes
  • 📰 Newsweek
  • ⏱ Reading Time:
  • 34 sec. here
  • 2 min. at publisher
  • 📊 Quality Score:
  • News: 17%
  • Publisher: 52%

'I'd expected to see slowing down of the clock, but not a reversal,' geneticist Steve Horvath said. 'That felt kind of futuristic.'

Scientists believe it may be possible to reverse a person's biological age with a combination of drugs and growth hormones, based on evidence presented in the results of a small clinical study.

Even the scientists who worked on the study were surprised by the results. At the same time, some are urging caution as the results are still preliminary.."That felt kind of futuristic."Matthew Horwood/Getty "It may be that there is an effect," Wagner said."But the results are not rock solid because the study is very small and not well controlled."last week, the initial research tested the cocktail of common drugs on nine men between the ages of 51 and 65, all of whom were white. Initially, the study's primary objective was to observe the effectiveness and safety of using growth hormone to restore tissue in the thymus gland.

Resumimos esta notícia para que você possa lê-la rapidamente. Se você se interessou pela notícia, pode ler o texto completo aqui. Consulte Mais informação:

Newsweek /  🏆 468. in US

Brasil Últimas Notícias, Brasil Manchetes

Similar News:Você também pode ler notícias semelhantes a esta que coletamos de outras fontes de notícias.

Ariana Grande Wants Mac Miller's Drug Dealer ConvictedAriana Grande Wants Mac Miller's Drug Dealer ConvictedAriana Grande wants the person or persons who supplied Mac Miller drugs to do time for contributing to his death.
Consulte Mais informação »

Overdose Data to Action | Drug Overdose | CDC Injury CenterOverdose Data to Action | Drug Overdose | CDC Injury Center
Consulte Mais informação »

Q&A: How the future of medicine looks to the FDA’s top drug regulatorQ&A: How the future of medicine looks to the FDA’s top drug regulatorA Q&A With Dr. Janet Woodcock, director of the FDA’s Center for Drug Evaluation and Research.
Consulte Mais informação »

Japan drug firm bets $3 bln on castoffs and hypeJapan drug firm bets $3 bln on castoffs and hypeSumitomo Dainippon’s growth has stalled and its pipeline is bare. It’s paying a lofty price for pieces of Roivant Sciences, which has scooped up dozens of compounds from Big Pharma but has yet to produce a marketed drug. This dream-chasing is unlikely to have a happy ending.
Consulte Mais informação »



Render Time: 2025-04-18 03:20:16